Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review-Reference-Cited by-同舟云学术

Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review

Published:2015-08-25 Issue:6 Volume:76 Page:296-317
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Ali Saira R.¹,Humphreys Karen J.¹,McKinnon Ross A.¹,Michael Michael Z.¹²

Affiliation:

1. Flinders Centre for Innovation in Cancer; School of Medicine, Flinders University; Adelaide South Australia Australia

2. Department of Gastroenterology and Hepatology; Flinders Medical Centre; Adelaide South Australia Australia

Funder

Cancer Council SA's Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21268/fullpdf

Reference186 articles.

1. Phase I study of pazopanib (PAZ) in combination with abexinostat (ABX) in patients (Pts) with metastatic solid tumors;Aggarwal;J Clin Oncol (2014 ASCO Meeting abstracts),2014

2. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia;Agirre;Cancer Res,2009

3. New nomenclature for chromatin-modifying enzymes;Allis;Cell,2007

4. Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish;Aluru;Neurotoxicol Teratol,2013

5. Phase I trial of a new schedule of romidepsin in patients with advanced cancers;Amiri-Kordestani;Clin Cancer Res,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium Butyrate as Histone Deacetylase Inhibitor Can Alter miR-101, ZEB1, ZEB2, and E-cadherin Expression in MDA-MB-468 Cells as Triple Negative Breast Cancer Cells;International Journal of Cancer Management;2024-01-07

2. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines;International Journal of Molecular Sciences;2023-09-26

3. MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review;Medical Oncology;2023-09-15

4. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?;Pathology - Research and Practice;2023-08

5. Defining epigenetic literacy: How to integrate epigenetics into the biology curriculum;Journal of Research in Science Teaching;2023-03-02